ENHANCEMENT OF γδ T CELL ANTITUMOR ACTIVITY AGAINST PROSTATE CANCER CELL THROUGH TOLL-LIKE RECEPTOR 2 AND 3 LIGAND DEPENDENT ACTIVATION

被引：0
|
作者：
Suzuki, Toru
Acharya, Bishnu
Terao, Shuji
Nojima, Michio
Yamamoto, Shingo
Gotoh, Akinobu
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.145
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
96
引用
收藏
页码：E39 / E40
页数：2
相关论文
共 50 条
  • [21] GANGLIOSIDES INDUCE SPINAL CORD GLIAL CELL ACTIVATION AND PAIN HYPERSENSITIVITY THROUGH TOLL-LIKE RECEPTOR 2
    You, B.
    Kim, D.
    Lee, S. J.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 207 - 207
  • [22] PROGRAMMED CELL DEATH AND TOLL-LIKE RECEPTOR ACTIVATION IN ARTICULAR CARTILAGE
    Stolberg-Stolberg, J.
    Boettcher, A.
    Sherwood, J.
    Sambale, M.
    Raschke, M.
    Pap, T.
    Bertrand, J.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 : S70 - S71
  • [23] Critical role of Toll-like receptor signaling in NK cell activation
    Guo Qie
    Zhang Cai
    CHINESE SCIENCE BULLETIN, 2012, 57 (24): : 3192 - 3202
  • [24] Critical role of Toll-like receptor signaling in NK cell activation
    GUO Qie & ZHANG Cai Institute of Immunopharmacology & Immunotherapy
    Science Bulletin, 2012, (24) : 3192 - 3202
  • [25] G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling
    L G Schuettpelz
    J N Borgerding
    M J Christopher
    P K Gopalan
    M P Romine
    A C Herman
    J R Woloszynek
    A M Greenbaum
    D C Link
    Leukemia, 2014, 28 : 1851 - 1860
  • [26] Toll-like receptor 2 activation implicated in oral squamous cell carcinoma development
    Ikehata, Naoki
    Takanashi, Masakatsu
    Satomi, Takafumi
    Watanabe, Masato
    Hasegawa, On
    Kono, Michihide
    Enomoto, Ai
    Chikazu, Daichi
    Kuroda, Masahiko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (03) : 2227 - 2234
  • [27] G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling
    Schuettpelz, L. G.
    Borgerding, J. N.
    Christopher, M. J.
    Gopalan, P. K.
    Romine, M. P.
    Herman, A. C.
    Woloszynek, J. R.
    Greenbaum, A. M.
    Link, D. C.
    LEUKEMIA, 2014, 28 (09) : 1851 - 1860
  • [28] Combination therapy by Toll-like receptor 3 activation and chemotherapeutics synergistically induces cancer cell death.
    Glavan, Tanja Matijevic
    Verillaud, Benjamin
    Busson, Pierre
    Pavelic, Jasminka
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [29] Pathogen dependent dendritic cell maturaton and toll-like receptor expression
    Tsujimoto, H
    Efron, P
    Matsumoto, T
    Tschoeke, S
    Ungaro, R
    Lanz, J
    Ono, S
    Mochizuki, H
    Moldawer, LL
    SHOCK, 2004, 21 : 27 - 28
  • [30] Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components
    Hashimoto, M
    Tawaratsumida, K
    Kariya, H
    Aoyama, K
    Tamura, T
    Suda, Y
    INTERNATIONAL IMMUNOLOGY, 2006, 18 (02) : 355 - 362
12345